BRIEF-Crescita Therapeutics Q4 Net Loss Per Share $0.59

March 28 (Reuters) - Crescita Therapeutics Inc:

* CRESCITA THERAPEUTICS REPORTS 2017 FOURTH QUARTER AND YEAR END RESULTS

* QTRLY NET LOSS PER SHARE FROM CONTINUING OPERATIONS $0.59

* QTRLY REVENUE C$2.4 MILLION VERSUS C$2.2 MILLION

* CASH AND CASH EQUIVALENTS WERE $7.0 MILLION AS AT DECEMBER 31, 2017 COMPARED TO $9.8 MILLION AS AT DECEMBER 31, 2016 Source text for Eikon: Further company coverage: